Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of BKM 120 for Patients With Recurrent Glioblastoma and Activated PI3K Pathway

NCT01339052 is registered in ClinicalTrials.gov with L. Nicolas Gonzalez Castro, MD, PhD as lead sponsor.

NCT NCT01339052
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01339052 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of BKM 120 for Patients With Recurrent Glioblastoma and Activated PI3K Pathway
Lead sponsor
L. Nicolas Gonzalez Castro, MD, PhD
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2011
Completion date
February 28, 2019
Enrollment
65 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma